Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$920K Buy
4,370
+2,352
+117% +$504K 0.02% 654
2026
Q1
$446K Buy
2,018
+530
+36% +$130K 0.01% 782
2025
Q4
$377K Sell
1,488
-675
-31% -$170K 0.01% 913
2025
Q3
$530K Buy
+2,163
New +$518K 0.01% 788
2025
Q1
$927K Buy
4,089
+748
+22% +$165K 0.03% 492
2024
Q4
$687K Sell
3,341
-117
-3% -$25.7K 0.02% 519
2024
Q3
$839K Buy
+3,458
New +$809K 0.03% 434
2024
Q1
Sell
-1,004
Closed -$221K 748
2023
Q4
$221K Sell
1,004
-45
-4% -$9.52K 0.01% 626
2023
Q3
$230K Buy
1,049
+42
+4% +$9.5K 0.02% 573
2023
Q2
$227K Buy
+1,007
New +$202K 0.02% 582

Other funds holding STE

Caprock Group's STE Position: Q2 2026 in Review

Caprock Group increased its Steris (STE) stake by 117% in Q2 2026, buying an estimated $504K and bringing the position to 4,370 shares worth $920K. The position accounts for 0.02% of the portfolio, ranked #654.

Caprock Group first reported a position in STE in Q2 2023 and has held it in 10 quarters since. The position peaked at $927K in Q1 2025. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Caprock Group held 4,370 shares of Steris worth $920K as of Q2 2026.
  • Caprock Group bought 2,352 Steris shares in Q2 2026, an estimated $504K.
  • Steris made up 0.02% of Caprock Group's portfolio in Q2 2026, its #654 holding.
  • Caprock Group first reported a position in Steris in Q2 2023 and has held it in 10 quarters since.
  • Caprock Group's Steris position peaked at $927K in Q1 2025.
  • 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.